% | $
Quotes you view appear here for quick access.


  • razor28461 razor28461 Feb 7, 2014 10:45 AM Flag

    Anyone know what we are waiting for?

    Been holding ACTC for years but I wonder why management can't provide any data. Phase I has been over for months and results were suppose to be issued in December. Can't understand why it takes months to provide the results. All they were trying to prove in Phase I is whether their process was safe enough to continue into Phase II. Shouldn't be that big of a deal. Also, has anyone ever seen any formal written data that suggest the ACTC stem cells has improved the sight of anyone they treated? I don't need smart response, just facts.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Hi Razor, It often takes several months from time of article data submission until actual publication. Time for very busy professional Ophthalmologists/Ph.D academics to review the data and recommend changes, collation of this professional feedback and return to ACTC scientists for revisions. Resubmission, and then getting into the actual publication queue. In short, I do not view this time period of waiting to be extraordinary. Also, a friend of mine, who is a practicing Ophthalmologist, says that reversal of this type of macular degeneration simply NEVER happens. He also says that if it continues to be safe, and the vision improvement is validated, patients would be lined up at his office door.

      Sentiment: Buy

    • Here is a fact razor. You are not a shareholder. If you had done your DD you would know the answer.

    • Phase 1 has not been completed for months and based on the last information that was received has at least a few more patients to inject. I would also note that their has been no clear distinction as to whether cohort 4 has officially been removed or not.